Roseburia Intestinalis

Overview

Roseburia intestinalis is a Gram-positive, obligate anaerobic member of the Lachnospiraceae family (Firmicutes). It is one of the most important butyrate producers in the human colon, converting dietary fiber into butyrate — the primary energy source for colonocytes and a key regulator of intestinal immune homeostasis.

Metal Dependencies

R. intestinalis requires iron for its electron transport chain and butyrate biosynthesis enzymes, yet it lacks the aggressive iron acquisition systems (siderophores) of Proteobacteria. This asymmetry means that when luminal iron rises during inflammation, iron-scavenging pathogens outcompete R. intestinalis, reducing butyrate output precisely when the gut needs it most.

Ecological Role

In a healthy, fiber-rich colon, R. intestinalis is a dominant fermenter. Its butyrate output maintains epithelial oxygen consumption, preserving the anaerobic environment that favors beneficial obligate anaerobes over facultative pathogens. Its flagellin interacts with TLR5 to promote anti-inflammatory IL-10 production. Loss of R. intestinalis initiates a vicious cycle: less butyrate, more oxygen, more Proteobacteria, more inflammation.

Conditions Associated

Depletion of R. intestinalis is a consistent signature across inflammatory bowel disease, type 2 diabetes, and colorectal cancer. Its abundance responds positively to dietary fiber interventions and negatively to high-fat, low-fiber diets and oral iron supplementation.

Cross-References

References (5)

  1. Ghorbani M, Joseph GBS, Tew MM et al. (2024). Functional Associations of the Gut Microbiome with Dopamine, Serotonin, and BDNF in Schizophrenia: A Pilot Study. Egyptian Journal of Neurology, Psychiatry and Neurosurgery. doi:10.1186/s41983-024-00901-0
  2. Friederike Gutmann, Lina Samira Bahr, Ulrike Bruning et al. (2025). Functional Microbiome Reprogramming Links Dietary Interventions to Neuroinflammatory Outcomes in Multiple Sclerosis. Research Square (preprint). doi:10.21203/rs.3.rs-7434844/v1
  3. Hiroshi Nishiwaki, Jun Ueyama, Mikako Ito et al. (2024). Nishiwaki 2024 — Meta-analysis of shotgun sequencing of gut microbiota in Parkinson's disease (6 countries, riboflavin/biotin pathway depletion). npj Parkinson's Disease. doi:10.1038/s41531-024-00724-z
  4. Debora Pietrucci, Adelaide Ferroni, Valeria Valente et al. (2020). Pietrucci 2020 -- Potential of Prebiotic Butyrogenic Fibers in Parkinson's Disease. Frontiers in Neurology. doi:10.3389/fneur.2020.00643
  5. Md. Mominur Rahman, Fahadul Islam, Md. Harun-Or-Rashid et al. (2022). The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation. Frontiers in Cellular and Infection Microbiology. doi:10.3389/fcimb.2022.903570